Global hematology analyzer market to reach USD 12.1 billion by 2027.Global hematology analyzer market is valued at approximately USD 7.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.9 % over the forecast period 2021-2027. Hematology analyzers are made up of a number of analytical modules that each have their own set of sample preparation methods. Viruses, anaemia, infections, cancer, genetic disorders, and diabetes are just a few of the diseases they can help diagnose. It also regulates the amount of illicit and medicinal substances in the blood. Hematology analyzers are used by research organizations, hospitals, and clinical testing laboratories, to name a few. Analyzers are specialized computers that determine the presence and count of several types of cellular components in blood samples. All of the aforementioned processes aid in the screening and analysis of diseases, and are thus frequently employed by physicians and doctors around the world. Blood diseases have become a global health problem with a variety of causes and significant fatality rates. Every year, millions of people of all ages are affected by blood illnesses such as anaemia, blood malignancies, hemorrhagic ailments, and blood infections. According to the Commonwealth of Australia, more than 330,000 affected infants are born each year (83 percent sickle cell diseases and 17 percent thalassemias), roughly 7% of pregnant women are carriers of haemoglobin disorders, and more than 1% of couples are at risk worldwide. According to the World Federation of Hemophilia, the global prevalence of haemophilia in men in 2019 was estimated to be around 17 per 100,000 men. Similarly, according to the Global Hemophilia Care 2019 study, over 1,125,000 men globally have an inherited bleeding problem, with 418,000 of those suffering from the most severe form of the disease. Early detection and treatment are the most effective approaches to protect a patient's quality of life if they have a blood cell issue. As a result, the market is projected to be driven in the future by the rising prevalence of blood disorders. However, high cost of hematology analyzers may impede the market growth over the forecast years.

The regional analysis of the Global hematology analyzer market is segmented for the key regions such as North America, Europe, Asia Pacific, Latin America, and Rest of the World (ROW). North America is the dominating region across the world in terms of market share due to rising incidence of patients suffering from blood disorders in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to rising demand for blood transfusions across APAC.

Major market player included in this report are:

Abbott Laboratories
Beckman Coulter Inc.
Bio-Rad Laboratories
Boule Diagnostics AB
F Hoffmann-La Roche Ltd
Horiba Ltd
Nihon Kohden Corporation
Mindray Medical International Limited
Siemens Healthineers
Sysmex Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Instruments
Reagents
Services
By End user:
Hospitals
Clinical Laboratories
Research Institutes
Other End Users

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year -2018,2019
Base year -2020
Forecast period - 2021 to 2027.

Target Audience of the Global hematology analyzer market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors